Relapsing Forms of Multiple Sclerosis Completed Phase 4 Trials for Water (DB09145)

IndicationStatusPhase
DBCOND0036449 (Relapsing Forms of Multiple Sclerosis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01216072A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple SclerosisTreatment